The value of quantitative patient preferences in regulatory benefit-risk assessment

Mart oude Egbrink; Maarten IJzerman

doi:10.3402/jmahp.v2.22761

The value of quantitative patient preferences in regulatory benefit-risk assessment

Mart oude Egbrink, Maarten IJzerman^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

34 Citations (Scopus)

3 Downloads (Pure)

Abstract

Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.

Original language	English
Article number	22761
Journal	Journal of Market Access and Health Policy
Volume	2
Issue number	1
Early online date	1 Apr 2014
DOIs	https://doi.org/10.3402/jmahp.v2.22761
Publication status	Published - 2014
Externally published	Yes

Bibliographical note

Funding Information:
This article has been partly supported by an educational grant from Université Claude Bernard Lyon I, France.

Publisher Copyright:
© 2014 Mart oude Egbrink and Maarten IJzerman.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3402/jmahp.v2.22761Licence: CC BY

The value of quantitative patient preferences in regulatory benefit-risk assessmentFinal published version, 437 KBLicence: CC BY

Cite this

@article{f117f3581db34e13b3ec11eee0f1e60f,

title = "The value of quantitative patient preferences in regulatory benefit-risk assessment",

abstract = "Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.",

author = "Egbrink, {Mart oude} and Maarten IJzerman",

note = "Funding Information: This article has been partly supported by an educational grant from Universit{\'e} Claude Bernard Lyon I, France. Publisher Copyright: {\textcopyright} 2014 Mart oude Egbrink and Maarten IJzerman.",

year = "2014",

doi = "10.3402/jmahp.v2.22761",

language = "English",

volume = "2",

journal = "Journal of Market Access and Health Policy",

issn = "2001-6689",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "1",

}

TY - JOUR

T1 - The value of quantitative patient preferences in regulatory benefit-risk assessment

AU - Egbrink, Mart oude

AU - IJzerman, Maarten

N1 - Funding Information: This article has been partly supported by an educational grant from Université Claude Bernard Lyon I, France. Publisher Copyright: © 2014 Mart oude Egbrink and Maarten IJzerman.

PY - 2014

Y1 - 2014

N2 - Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.

AB - Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.

UR - http://www.scopus.com/inward/record.url?scp=84930618901&partnerID=8YFLogxK

U2 - 10.3402/jmahp.v2.22761

DO - 10.3402/jmahp.v2.22761

M3 - Article

C2 - 27226836

AN - SCOPUS:84930618901

SN - 2001-6689

VL - 2

JO - Journal of Market Access and Health Policy

JF - Journal of Market Access and Health Policy

IS - 1

M1 - 22761

ER -

The value of quantitative patient preferences in regulatory benefit-risk assessment

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this